|
Volumn 6, Issue 2, 1997, Pages 147-150
|
Antifungals targeted to the cell wall
|
Author keywords
amphotericin B; BMS 181184; cell wall acting antifungals; immunocompromised patients; L 743,872; LY 303366; nikkomycin Z; trimethoprim sulfamethoxazole
|
Indexed keywords
1,3 ALPHA GLUCAN SYNTHASE;
2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL;
4 [4 [4 [4 [[5 (2,4 DIFLUOROPHENYL)TETRAHYDRO 5 (1H 1,2,4 TRIAZOL 1 YLMETHYL)FURAN 3 YL]METHOXY]PHENYL] 1 PIPERAZINYL] PHENYL] 2,4 DIHYDRO 2 (1 ETHYL 2 HYDROXYPROPYL) 3H 1,2,4 TRIAZOLE 3 ONE;
AMPHOTERICIN B;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B LIPID COMPLEX;
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
AUREOBASIDIN A;
CASPOFUNGIN;
CHITIN SYNTHASE;
COTRIMOXAZOLE;
ECHINOCANDIN B DERIVATIVE;
FLUCONAZOLE;
FLUCYTOSINE;
ITRACONAZOLE;
KETOCONAZOLE;
MICROBIAL ENZYME;
NIKKOMYCIN Z;
PNEUMOCANDIN DERIVATIVE;
POSACONAZOLE;
PYRROLE DERIVATIVE;
RAVUCONAZOLE;
UNCLASSIFIED DRUG;
VORICONAZOLE;
CELL WALL;
DRUG FORMULATION;
DRUG RESEARCH;
DRUG TARGETING;
FUNGUS;
HUMAN;
IMMUNE DEFICIENCY;
MARKET;
MYCOSIS;
NONHUMAN;
SHORT SURVEY;
|
EID: 0031058460
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.6.2.147 Document Type: Short Survey |
Times cited : (14)
|
References (7)
|